Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Daiichi Sankyo
Fuji
Medtronic
Johnson and Johnson
Harvard Business School
US Army
Argus Health
Farmers Insurance
Chubb

Generated: October 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021472

« Back to Dashboard
NDA 021472 describes MIDOL LIQUID GELS, which is a drug marketed by Bionpharma Inc and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the MIDOL LIQUID GELS profile page.

The generic ingredient in MIDOL LIQUID GELS is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and sixty-two suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.

Summary for NDA: 021472

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 021472

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MIDOL LIQUID GELS
ibuprofen
CAPSULE;ORAL 021472 NDA Bayer HealthCare LLC - Consumer Care 0280-8080 0280-8080-20 1 BOTTLE in 1 CARTON (0280-8080-20) > 20 CAPSULE, LIQUID FILLED in 1 BOTTLE
MIDOL LIQUID GELS
ibuprofen
CAPSULE;ORAL 021472 NDA Bayer HealthCare LLC - Consumer Care 0280-8080 0280-8080-25 1 BOTTLE in 1 CARTON (0280-8080-25) > 25 CAPSULE, LIQUID FILLED in 1 BOTTLE

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:CAPSULE;ORALStrength200MG
Approval Date:Oct 18, 2002TE:RLD:Yes
Patent:► SubscribePatent Expiration:Jun 25, 2018Product Flag?Substance Flag?Delist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Cerilliant
Queensland Health
Colorcon
Argus Health
UBS
AstraZeneca
Daiichi Sankyo
Farmers Insurance
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot